Skip to main content

Table 2 Summary of diagnostic criteria estimates and their 95% confidence intervals (95% CIs)

From: Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis

Subgroup

SEN (95%CI)

SPE (95%CI)

PLR (95%CI)

NLR (95%CI)

DOR (95%CI)

Type

 Pro

0.92 (0.89, 0.94)

0.59 (0.49, 0.68)

2.26 (1.89, 2.70)

0.10 (0.06, 0.15)

21.12 (12.83, 34.76)

 Retro

0.73 (0.65, 0.79)

0.65 (0.55, 0.74)

1.98 (1.60, 2.45)

0.32 (0.23, 0.47)

5.88 (3.73, 9.28)

Ethnicity

 Asian

0.81 (0.74, 0.86)

0.64 (0.53, 0.74)

2.23 (1.71, 2.93)

0.23 (0.15, 0.35)

9.31 (5.03, 17.23)

 Caucasian

0.89 (0.84, 0.92)

0.60 (0.51, 0.69)

2.16 (1.83, 2.55)

0.13 (0.08, 0.20)

15.28 (9.45, 24.68)

miRNA profiling

 Single miRNA

0.86 (0.81, 0.89)

0.59 (0.51, 0.66)

2.02 (1.79, 2.33)

0.17 (0.12, 0.26)

11.11 (7.55, 16.34)

 Multiple miRNA

0.90 (0.75, 0.97)

0.74 (0.59, 0.85)

3.21 (2.06, 5.01)

0.09 (0.03, 0.28)

30.06 (8.58, 105.37)

 miRNA 200 family

0.90 (0.80, 0.95)

0.58 (0.43, 0.72)

1.98 (1.61, 2.44)

0.11 (0.07, 0.17)

15.48 (7.15, 33.51)

 miRNA 200c

0.85 (0.67, 0.94)

0.52 (0.22, 0.81)

1.88 (1.17, 3.03)

0.19 (0.06, 0.57)

8.84 (3.20, 24.40)

overall

0.89 (0.84, 0.93)

0.64 (0.56, 0.72)

2.18 (1.90, 2.51)

0.15 (0.11, 0.22)

13.21 (9.00, 19.38)

  1. SEN sensitivity, SPE specificity, PLR positive likelihood ratio, NLR negative likelihood ratio, DOR diagnostic odds ratio, miRNA microRNA, Pro prospective, Retro retrospective.